Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Role of Genetic Susceptibility in the Development of Bronchopulmonary Dysplasia.

Parad RB, Winston AB, Kalish LA, Gupta M, Thompson I, Sheldon Y, Morey J, Van Marter LJ.

J Pediatr. 2018 Dec;203:234-241.e2. doi: 10.1016/j.jpeds.2018.07.099. Epub 2018 Oct 1.

PMID:
30287068
2.

Vitamin D and bronchopulmonary dysplasia in preterm infants.

Joung KE, Burris HH, Van Marter LJ, McElrath TF, Michael Z, Tabatabai P, Litonjua AA, Weiss ST, Christou H.

J Perinatol. 2016 Oct;36(10):878-82. doi: 10.1038/jp.2016.115. Epub 2016 Jul 28.

3.

Automatic measurement of interburst interval in premature neonates using range EEG.

Navakatikyan MA, O'Reilly D, Van Marter LJ.

Clin Neurophysiol. 2016 Feb;127(2):1233-1246. doi: 10.1016/j.clinph.2015.11.008. Epub 2015 Nov 19.

PMID:
26690783
4.

Hemopexin in severe inflammation and infection: mouse models and human diseases.

Lin T, Maita D, Thundivalappil SR, Riley FE, Hambsch J, Van Marter LJ, Christou HA, Berra L, Fagan S, Christiani DC, Warren HS.

Crit Care. 2015 Apr 15;19:166. doi: 10.1186/s13054-015-0885-x.

5.

Stooling pattern and early nutritional exposures associated with necrotizing enterocolitis in premature infants.

Gregory KE, Winston AB, Meller S, Ismail A, Van Marter LJ.

J Perinat Neonatal Nurs. 2015 Jan-Mar;29(1):60-8. doi: 10.1097/JPN.0000000000000081.

6.

The relationship between TSH and systemic inflammation in extremely preterm newborns.

Soto-Rivera CL, Fichorova RN, Allred EN, Van Marter LJ, Shah B, Martin CR, Agus MS, Leviton A.

Endocrine. 2015 Mar;48(2):595-602. doi: 10.1007/s12020-014-0329-4. Epub 2014 Jul 6.

7.

Early blood gas predictors of bronchopulmonary dysplasia in extremely low gestational age newborns.

Sriram S, Condie J, Schreiber MD, Batton DG, Shah B, Bose C, Laughon M, Van Marter LJ, Allred EN, Leviton A.

Int J Pediatr. 2014;2014:210218. doi: 10.1155/2014/210218. Epub 2014 May 15.

8.

Urinary intestinal fatty acid binding protein predicts necrotizing enterocolitis.

Gregory KE, Winston AB, Yamamoto HS, Dawood HY, Fashemi T, Fichorova RN, Van Marter LJ.

J Pediatr. 2014 Jun;164(6):1486-8. doi: 10.1016/j.jpeds.2014.01.057. Epub 2014 Mar 15.

9.

Vitamin D status among preterm and full-term infants at birth.

Burris HH, Van Marter LJ, McElrath TF, Tabatabai P, Litonjua AA, Weiss ST, Christou H.

Pediatr Res. 2014 Jan;75(1-1):75-80. doi: 10.1038/pr.2013.174. Epub 2013 Oct 11.

10.

Low urine vascular endothelial growth factor levels are associated with mechanical ventilation, bronchopulmonary dysplasia and retinopathy of prematurity.

Levesque BM, Kalish LA, Winston AB, Parad RB, Hernandez-Diaz S, Phillips M, Zolit A, Morey J, Gupta M, Mammoto A, Ingber DE, Van Marter LJ.

Neonatology. 2013;104(1):56-64. doi: 10.1159/000351040. Epub 2013 May 24.

11.

Nonsteroidal antiinflammatory drugs in late pregnancy and persistent pulmonary hypertension of the newborn.

Van Marter LJ, Hernandez-Diaz S, Werler MM, Louik C, Mitchell AA.

Pediatrics. 2013 Jan;131(1):79-87. doi: 10.1542/peds.2012-0496. Epub 2012 Dec 3. Review.

12.

Systemic inflammation associated with mechanical ventilation among extremely preterm infants.

Bose CL, Laughon MM, Allred EN, O'Shea TM, Van Marter LJ, Ehrenkranz RA, Fichorova RN, Leviton A; ELGAN Study Investigators.

Cytokine. 2013 Jan;61(1):315-22. doi: 10.1016/j.cyto.2012.10.014. Epub 2012 Nov 11.

13.

Peak-to-peak amplitude in neonatal brain monitoring of premature infants.

O'Reilly D, Navakatikyan MA, Filip M, Greene D, Van Marter LJ.

Clin Neurophysiol. 2012 Nov;123(11):2139-53. doi: 10.1016/j.clinph.2012.02.087. Epub 2012 May 17.

PMID:
22608473
14.

Innate immune activation in neonatal tracheal aspirates suggests endotoxin-driven inflammation.

Nathe KE, Mancuso CJ, Parad R, Van Marter LJ, Martin CR, Stoler-Barak L, Philbin VJ, Phillips MF, Palmer CD, Levy O.

Pediatr Res. 2012 Aug;72(2):203-11.

15.

Necrotizing enterocolitis in the premature infant: neonatal nursing assessment, disease pathogenesis, and clinical presentation.

Gregory KE, Deforge CE, Natale KM, Phillips M, Van Marter LJ.

Adv Neonatal Care. 2011 Jun;11(3):155-64; quiz 165-6. doi: 10.1097/ANC.0b013e31821baaf4.

16.

Patterns of blood protein concentrations of ELGANs classified by three patterns of respiratory disease in the first 2 postnatal weeks.

Laughon M, Bose C, Allred EN, O'shea TM, Ehrenkranz RA, VAN Marter LJ, Leviton A; ELGAN STUDY INVESTIGATORS.

Pediatr Res. 2011 Sep;70(3):292-6. doi: 10.1203/PDR.0b013e3182274f35.

17.

Blood protein concentrations in the first two postnatal weeks that predict bronchopulmonary dysplasia among infants born before the 28th week of gestation.

Bose C, Laughon M, Allred EN, Van Marter LJ, O'Shea TM, Ehrenkranz RA, Fichorova R, Leviton A; Elgan Study Investigators.

Pediatr Res. 2011 Apr;69(4):347-53. doi: 10.1203/PDR.0b013e31820a58f3.

18.

Transitional hypothermia in preterm newborns.

Bhatt DR, White R, Martin G, Van Marter LJ, Finer N, Goldsmith JP, Ramos C, Kukreja S, Ramanathan R.

Adv Neonatal Care. 2010 Oct;10(5 Suppl):S15-7. doi: 10.1097/ANC.0b013e3181ef7dfd.

PMID:
20838079
19.

Does bronchopulmonary dysplasia contribute to the occurrence of cerebral palsy among infants born before 28 weeks of gestation?

Van Marter LJ, Kuban KC, Allred E, Bose C, Dammann O, O'Shea M, Laughon M, Ehrenkranz RA, Schreiber MD, Karna P, Leviton A; ELGAN Study Investigators.

Arch Dis Child Fetal Neonatal Ed. 2011 Jan;96(1):F20-9. doi: 10.1136/adc.2010.183012. Epub 2010 Aug 24.

PMID:
20736416
20.

Antecedents of chronic lung disease following three patterns of early respiratory disease in preterm infants.

Laughon M, Bose C, Allred EN, O'Shea TM, Ehrenkranz RA, Van Marter LJ, Leviton A; ELGAN Study Investigators.

Arch Dis Child Fetal Neonatal Ed. 2011 Mar;96(2):F114-20. doi: 10.1136/adc.2010.182865. Epub 2010 Aug 5.

21.

Fetal placental thrombosis and neonatal implications.

Wintermark P, Boyd T, Parast MM, Van Marter LJ, Warfield SK, Robertson RL, Ringer SA.

Am J Perinatol. 2010 Mar;27(3):251-6. doi: 10.1055/s-0029-1239486. Epub 2009 Oct 5. Review.

22.

Epidemiology of bronchopulmonary dysplasia.

Van Marter LJ.

Semin Fetal Neonatal Med. 2009 Dec;14(6):358-66. doi: 10.1016/j.siny.2009.08.007. Epub 2009 Sep 26. Review.

PMID:
19783238
23.

Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation.

Bose C, Van Marter LJ, Laughon M, O'Shea TM, Allred EN, Karna P, Ehrenkranz RA, Boggess K, Leviton A; Extremely Low Gestational Age Newborn Study Investigators.

Pediatrics. 2009 Sep;124(3):e450-8. doi: 10.1542/peds.2008-3249. Epub 2009 Aug 17.

24.

Chronic lung disease and developmental delay at 2 years of age in children born before 28 weeks' gestation.

Laughon M, O'Shea MT, Allred EN, Bose C, Kuban K, Van Marter LJ, Ehrenkranz RA, Leviton A; ELGAN Study Investigators.

Pediatrics. 2009 Aug;124(2):637-48. doi: 10.1542/peds.2008-2874. Epub 2009 Jul 20.

25.

Endotoxin-directed innate immunity in tracheal aspirates of mechanically ventilated human neonates.

Nathe KE, Parad R, Van Marter LJ, Lund CA, Suter EE, Hernandez-diaz S, Boush EB, Ikonomu E, Gallington L, Morey JA, Zeman AM, Mcnamara M, Levy O.

Pediatr Res. 2009 Aug;66(2):191-6. doi: 10.1203/PDR.0b013e3181aa33d7.

26.

Patterns of respiratory disease during the first 2 postnatal weeks in extremely premature infants.

Laughon M, Allred EN, Bose C, O'Shea TM, Van Marter LJ, Ehrenkranz RA, Leviton A; ELGAN Study Investigators.

Pediatrics. 2009 Apr;123(4):1124-31. doi: 10.1542/peds.2008-0862.

27.

Transitional hypothermia in preterm newborns.

Bhatt DR, White R, Martin G, Van Marter LJ, Finer N, Goldsmith JP, Ramos C, Kukreja S, Ramanathan R.

J Perinatol. 2007 Dec;27 Suppl 2:S45-7. Review.

PMID:
18034181
28.
29.

Risk factors for persistent pulmonary hypertension of the newborn.

Hernández-Díaz S, Van Marter LJ, Werler MM, Louik C, Mitchell AA.

Pediatrics. 2007 Aug;120(2):e272-82.

PMID:
17671038
30.

Factors associated with treatment for hypotension in extremely low gestational age newborns during the first postnatal week.

Laughon M, Bose C, Allred E, O'Shea TM, Van Marter LJ, Bednarek F, Leviton A; ELGAN Study Investigators.

Pediatrics. 2007 Feb;119(2):273-80.

31.

Progress in discovery and evaluation of treatments to prevent bronchopulmonary dysplasia.

Van Marter LJ.

Biol Neonate. 2006;89(4):303-12. Epub 2006 Jun 1. Review.

PMID:
16770070
32.

Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA.

N Engl J Med. 2006 Feb 9;354(6):579-87.

33.

Strategies for preventing bronchopulmonary dysplasia.

Van Marter LJ.

Curr Opin Pediatr. 2005 Apr;17(2):174-80. Review.

PMID:
15800407
34.

Antenatal glucocorticoids increase early total thyroxine levels in premature infants.

Martin CR, Van Marter LJ, Allred EN, Leviton A; Developmental Epidemiology Network.

Biol Neonate. 2005;87(4):273-80. Epub 2005 Feb 7.

PMID:
15703468
35.

Neonatology research for the 21st century: executive summary of the National Institute of Child Health and Human Development-American Academy of Pediatrics workshop. Part II: training issues.

Ariagno RL, Van Marter LJ, Higgins R, Raju TN; National Institute of Child Health and Human Development; American Academy of Pediatrics.

Pediatrics. 2005 Feb;115(2):475-9.

PMID:
15687458
36.

Research in neonatology for the 21st century: executive summary of the National Institute of Child Health and Human Development-American Academy of Pediatrics workshop. Part I: academic issues.

Raju TN, Ariagno RL, Higgins R, Van Marter LJ; National Institute of Child Health and Human Development; American Academy of Pediatrics.

Pediatrics. 2005 Feb;115(2):468-74.

PMID:
15687457
37.

Bronchopulmonary dysplasia is not associated with ultrasound-defined cerebral white matter damage in preterm newborns.

Dammann O, Allred EN, Van Marter LJ, Dammann CE, Leviton A; Developmental Epidemiology Network Investigators.

Pediatr Res. 2004 Feb;55(2):319-25. Epub 2003 Nov 6.

PMID:
14605242
38.

Clinical performance of an in-line, ex vivo point-of-care monitor: a multicenter study.

Billman GF, Hughes AB, Dudell GG, Waldman E, Adcock LM, Hall DM, Orsini EN Jr, Koska AJ, Van Marter LJ, Finer NN, Kulhavy JC, Feld RD, Widness JA.

Clin Chem. 2002 Nov;48(11):2030-43.

39.

Urine bombesin-like peptide elevation precedes clinical evidence of bronchopulmonary dysplasia.

Cullen A, Van Marter LJ, Allred EN, Moore M, Parad RB, Sunday ME.

Am J Respir Crit Care Med. 2002 Apr 15;165(8):1093-7.

PMID:
11956050
40.

Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants.

Van Marter LJ, Dammann O, Allred EN, Leviton A, Pagano M, Moore M, Martin C; Developmental Epidemiology Network Investigators.

J Pediatr. 2002 Feb;140(2):171-6.

PMID:
11865267
41.

Systemic hypotension and white-matter damage in preterm infants.

Dammann O, Allred EN, Kuban KC, Van Marter LJ, Pagano M, Sanocka U, Leviton A; Developmental Epidemiology Network.

Dev Med Child Neurol. 2002 Feb;44(2):82-90. Review.

42.

Risk of cranial ultrasound abnormalities in very-low-birth-weight infants conceived with assisted reproductive techniques.

Stewart JE, Allred EN, Collins M, Abbott J, Leviton A, Paneth N, Reuss ML, Susser M, Hegyi T, Hiatt M, Sanocka U, Shahrivar F, Van Marter LJ, Banogan P, Genest D, Heller D, Shen-Schwarz S, Dammann O, Kuban KC, Pagano M.

J Perinatol. 2002 Jan;22(1):37-45.

43.

Growth-restricted premature infants are at increased risk for low thyroxine.

Martin CR, Van Marter LJ, Allred EN, Leviton A.

Early Hum Dev. 2001 Sep;64(2):119-28.

PMID:
11440824
44.

Mediators of fetal inflammation in extremely low gestational age newborns.

Dammann O, Phillips TM, Allred EN, O'Shea TM, Paneth N, Van Marter LJ, Bose C, Ehrenkranz RA, Bednarek FJ, Naples M, Leviton A; ELGAN STUDY INVESTIGATORS.

Cytokine. 2001 Feb 21;13(4):234-9.

PMID:
11237431
45.

Antenatal glucocorticoid treatment does not reduce chronic lung disease among surviving preterm infants.

Van Marter LJ, Allred EN, Leviton A, Pagano M, Parad R, Moore M; Neonatology Committee for the Developmental Epidemiology Network.

J Pediatr. 2001 Feb;138(2):198-204.

PMID:
11233077
46.

Hypocarbia during the first 24 postnatal hours and white matter echolucencies in newborns < or = 28 weeks gestation.

Dammann O, Allred EN, Kuban KC, van Marter LJ, Stewart JE, Pagano M, Leviton A; Development Epidemiology Network Investigators.

Pediatr Res. 2001 Mar;49(3):388-93.

PMID:
11228265
47.

Inhaled nitric oxide reduces the need for extracorporeal membrane oxygenation in infants with persistent pulmonary hypertension of the newborn.

Christou H, Van Marter LJ, Wessel DL, Allred EN, Kane JW, Thompson JE, Stark AR, Kourembanas S.

Crit Care Med. 2000 Nov;28(11):3722-7.

PMID:
11098980
48.

Antecedents of clinically significant pulmonary hemorrhage among newborn infants.

Berger TM, Allred EN, Van Marter LJ.

J Perinatol. 2000 Jul-Aug;20(5):295-300.

49.

Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network.

Van Marter LJ, Allred EN, Pagano M, Sanocka U, Parad R, Moore M, Susser M, Paneth N, Leviton A.

Pediatrics. 2000 Jun;105(6):1194-201.

PMID:
10835057
50.

Pulmonary hypertension associated with nonketotic hyperglycinaemia.

Cataltepe S, van Marter LJ, Kozakewich H, Wessel DL, Lee PJ, Levy HL.

J Inherit Metab Dis. 2000 Mar;23(2):137-44.

PMID:
10801055

Supplemental Content

Loading ...
Support Center